Chronic renal failure syndrome
Therapeutic area
Nephrology
Rare disease
No
- Definition
- Impairment of the renal function due to chronic kidney damage.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Chronic renal failure syndrome
- Therapeutic area
- Nephrology
- chronic renal failure syndrome
- Chronic renal disease
- CRF - chronic renal failure
- chronic kidney failure
- chronic renal failure
- chronic renal failure disease
- kidney failure, chronic
- All therapeutic areas
- Nephrology
- Severity
- Severe
- MONDO ID
- MONDO:0024327
- Parent condition
- MONDO:0001106
Related records
Broader conditions (7)
- Chronic kidney disease
- Disease
- Disease by body system or component
- Human disease
- Kidney disorder
- Kidney failure
- Urinary system disorder
Trials (1,992)
- 123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients
- 13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients
- 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
- 2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula
- 24 Hour Use of the Wearable Artificial Kidney
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
- A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients
- A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
- A Clinical Study to Map the HLA Genomic Region in the Greek Population
- A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
- A Clinical Trial of IntensiVE Dialysis
- A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
- A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
- A Communication Tool to Assist Older Adults Facing Dialysis Choices
- A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial
- A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
- A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients
- A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Transplantation - A Prospective, Randomized Trial
- A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Approved drugs (6)
- Darbepoetin alfa
- Epoetin alfa
- Epoetin beta
- Folic acid
- Irbesartan
- Lanthanum carbonate
Drugs in development (59)
- Acetylcysteine Phase 3
- Adomeglivant Phase 1
- Alemtuzumab Phase 2
- Alisporivir Phase 1
- Angiotensin Phase 3
- Apabetalone Phase 1
- Balcinrenone Phase 2
- Belatacept Phase 3
- Carvedilol Phase 3
- Cinacalcet Phase 3
- Clopidogrel Phase 3
- Cyclophosphamide Phase 2
- Cyclosporine Phase 3
- Daclizumab Phase 3
- Dalteparin sodium Phase 3
- Dapagliflozin Phase 3
- Desidustat Phase 3
- Dexamethasone Phase 3
- Dextrose Phase 3
- Efalizumab Phase 1
Other linked drugs (9)
- Benazepril
- Bixalomer
- Epoetin theta
- Epoetin zeta
- Methoxy polyethylene glycol-epoetin beta
- Phenacetin
- Physioneal
- Tacrolimus
- Tenofovir disoproxil fumarate